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Over the past 25 years, the broad field of epigenetics and, over the past decade in particular, the emerging
field of neuroepigenetics have begun to have tremendous impact in the areas of learned behavior, neurotox-
icology, CNS development, cognition, addiction, and psychopathology. However, epigenetics is such a new
field that in most of these areas the impact is more in the category of fascinating implications as opposed to
established facts. In this brief commentary, I will attempt to address and delineate some of the open ques-
tions and areas of opportunity that discoveries in epigenetics are providing to the discipline of neuroscience.Introduction
Only infrequently do scientific discoveries force the recasting of
a centuries-long philosophical debate. However, over the last
25 years, and indeed largely over the last decade, the emerging
field of neuroepigenetics has necessitated the reformulation of
the fundamental existential question of nature versus nurture
(Sweatt, 2009). Based on recent discoveries in the broad field
of epigenetics, it no longer makes sense to debate nature versus
nurture. There is no longer a mechanistic dichotomy between
nature and nurture (or genes and environmental experience, as
is the more modern phrasing). Rather, it is now clear that
there is a dynamic interplay between genes and experience, a
clearly delineated and biochemically driven mechanistic inter-
face between nature and nurture. That mechanistic interface is
epigenetics.
The term epigenetics derives from Waddington’s coining of
the term ‘‘epigenesis’’ to capture his logical deduction that dur-
ing organismal development, a layer of mechanisms must surely
exist that resides above (epi) the level of the genes, which control
their output in order to specify cell fate determination. In terms of
the underlying biochemistry, there are two main epigenetic
mechanisms, DNA methylation and regulation of chromatin
structure via histone modifications (although see Table 1). These
mechanisms have mostly been explored in the context of organ-
ismal development. However, it is now clear that experience, be
it environmental toxins, maternal behavior, psychological or
physical stress, learning, drug exposure, or psychotrauma, leads
to active regulation of the chemical and three-dimensional struc-
ture of DNA in the nervous system, i.e., that experience regulates
epigenetic mechanisms in the CNS (Borrelli et al., 2008; Cham-
pagne and Curley, 2009; Day and Sweatt, 2010; Dulac, 2010;
Renthal and Nestler, 2008). These epigenomic changes lead to
alterations in gene readout (and who knows what else?) in cells
in the nervous system that trigger lasting, and in some cases
perpetual, changes in neural function.
The field of epigenetics has undergone an exponential expan-
sion as of late. A quick check of the PubMed publication data-
base reveals that about 98% of all the research published in
the broad area of epigenetics was published within the last
15 years. The search term epigenetics returns 1 publication in
1989, i.e., the year after Neuron was established. Last year
(2012) over 1,500 papers were published on epigenetics, an624 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.orders-of-magnitude increase over the 25 year time span that
is the focus of this special Neuron anniversary issue. Interesting
comparison searches for neuroscientists are memory, synapse,
and long-term potentiation, to place these numbers in context
(see Figure 1).
The Biochemical Mechanisms of Epigenetics
I will not go into detail concerning the basic molecular and
biochemical mechanisms that comprise the established epige-
netic toolkit, because those mechanisms have been reviewed
extensively in a number of other prior publications (Allis et al.,
2007;Campos and Reinberg, 2009; Lee et al., 2010; Levenson
and Sweatt, 2006; Turner, 2007), and the topic is too broad to
address in a short perspective article. However, in Table 1 I
have listed the major (known and emerging) players in the arena
of neuroepigenetics in order to introduce terms and provide
some basic background. I also will briefly describe the major
epigenetic molecular mechanisms listed in Table 1 in the
following few paragraphs in order to help make the rest of this
perspective piece comprehensible to those readers new to the
epigenetics milieu. Thus, I will introduce a few terms that one
needs to be familiar with before I launch into discussion of the
‘‘open questions in epigenetics’’ section that is the main thrust
of this perspective piece. Please keep in mind that in only a
few paragraphs I will be sparsely summarizing and broadly
oversimplifying the results of literally thousands of recent publi-
cations; for amore comprehensive treatment, please see the ref-
erences by Allis et al. (2008) and Sweatt et al. (2013).
It is worth noting that all of these modifications I will describe
have the basic biochemical characteristics of both regulating
gene function (transcription) without altering the DNA sequence
directly and of being (at least theoretically) capable of self-regen-
eration and self-perpetuation—in other words, of having the
capacity to trigger a persisting change in gene function, even
in the face of subsequent cell division or even organismal procre-
ation. The biochemical capacity of a specific chemical reaction
to trigger self-perpetuation is the defining characteristic of a pro-
cess involved in cellular information storage, aswas initially com-
mented upon in the neuroscience context by Francis Crick and
John Lisman almost 30 years ago (Crick, 1984; Lisman, 1985).
Epigenetic mechanisms also possess this defining characteristic
(Holliday, 1999).
Table 1. Major Biochemical Mechanisms in Neuroepigenetics
Covalent modification of DNA
DNA cytosine methylation
active cytosine demethylation
hydroxymethylcytosine formation
methylcytosine oxidation (5-formylcytosine, 5-carboxylcytosine)
Histone posttranslational modifications
lysine acetylation
lysine (mono/di/tri) and arginine (mono/di) methylation
serine/threonine phosphorylation
monoubiquitination
poly ADP-ribosylation
ATP-dependent chromatin remodeling (SWI-SNF)
Histone subunit exchange
H2A.Z
H3.3
RE1-silencing transcription factor (REST)/REST corepressor
(CoREST)/Sin3A system
Noncoding RNAs
piRNAs
microRNAs
small interfering RNAs (siRNAs)
small nuclear RNAs (snRNAs)
Line 1 retrotransposition
Prion protein-based mechanisms
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Covalent chemical modification of DNA, specifically cytosine
50-methylation, has been referred to as the prima donna of
epigenetics because it is an extremely powerful regulator of
gene transcription (Santos et al., 2005). As a first approxima-
tion, DNA methylation is the proximal molecular mechanism
that triggers, and perpetuates over the full lifespan, the com-
plete gene silencing in cells that is part and parcel of cell fate
determination and perpetuation (Bird, 2002). DNA cytosine
methylation is a core mechanism for silencing all the nonneuro-
nal genes in all the cells in the body that are not neurons, for
example. DNA cytosine methylation is the core driver of the
epigenesis mechanism that Waddington postulated to exist
(Holliday, 2006). In the existing literature, DNA cytosine methyl-
ation is described as occurring preferentially at cytosine-gua-
nine dinucleotide sequences in DNA (so-called CpG sites) and
is said to lead to attenuation of gene transcription. These gen-
eralizations are largely true, but based on recent discoveries it
is clear that cytosine methylation also occurs at non-CpG sites
and that cytosine methylation can also be associated with tran-
scriptional activation. This is the ambiguous nature of newly
emerging fields.
Besides DNA cytosine methylation, other chemical modifica-
tions of cytosine in DNA have also been documented to exist,
including 5-hydroxymethylcytosine (hmC) formation andmethyl-
cytosine oxidation to generate 5-formylcytosine and 5-carboxyl-
cytosine. The functional role(s) of these novel modifications arenot fully established, and this is a hot area of investigation in
the field at present.
A central dogma of the epigenetics field has been that once
DNA methylation patterns are established upon the genome in
terminally differentiated cells, thosemodifications are permanent
and essentially immutable. This view is aligned with the original
conception of epigenesis by Waddington, wherein he reasoned
that such mechanisms are necessary to perpetuate cellular
phenotype over an entire lifespan (Holliday, 2006). However, of
late it has become clear that so-called active cytosine demethy-
lation also occurs, wherein a previously methylated cytosine can
undergo a net reconversion back to the unmethylated state. This
mechanism (while likely rare in the overall context of the entire
genome and epigenome) appears to be particularly prominent
in two places: in the mature nervous system and in the fertilized
zygote undergoing generation of totipotent embryonic stem cells
(in other words, in the twomost highly plastic tissues in the body).
We will return to this idea later in the open questions section.
Histone posttranslational modifications are the second major
category of epigenetic biochemical mechanisms in cells, and
this area has a broad and rich literature (Jenuwein and Allis,
2001). Histone posttranslational modifications that have func-
tional consequences on gene readout are multitudinous,
including lysine acetylation, lysine mono/di/tri-methylation, argi-
nine mono/di-methylation, serine/threonine phosphorylation,
histone monoubiquitination, and histone poly ADP-ribosylation.
In the nucleus, histone proteins exist largely as octameric
complexes, which make up the core of the chromatin particle
around which most DNA is wrapped, forming a three-dimen-
sional histone/DNA complex that is itself a powerful regulator
of transcriptional efficacy. Histone posttranslational modifica-
tions regulate this structure in order to modulate transcriptional
readout of the associated gene.
Individual isoforms of histonemonomers can also be swapped
in and out of the octamer, a regulatory mechanism referred to as
histone subunit exchange. The histone H2A.Z and H3.3 iso-
forms, among others, are prominent participants in these subunit
exchange mechanisms and also regulate transcriptional efficacy
in a manner reminiscent of histone posttranslational modifica-
tions. Subunit exchange and posttranslational modifications
trigger either increases or decreases in transcription, depending
upon the particular modification, the particular histone isoform
involved, and even the context of other histone modifications
in which the modification resides. This attribute of these mecha-
nisms has given rise to the concept of a histone code, wherein
histone modifications are interpreted in situ as a combinatorial
code regulating gene transcription rates at specific loci across
the genome (Jenuwein and Allis, 2001; Borrelli et al., 2008, Lee
et al., 2010; Strahl and Allis, 2000; Wang et al., 2008). The impli-
cations of this sort of molecular/cellular information processing
within neurons is only beginning to be considered and addressed
at present (Wood et al., 2006).
A variety of other epigenetic molecular mechanisms are also in
play in neurons; however, I will only be able to touch on these
briefly due to space limitations.
ATP-dependent chromatin remodeling, which involves the
switch/sucrose nonfermentable (SWI-SNF) biochemical regula-
tory system, can regulate the affinity of the histone octamerNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 625
Figure 1. Yearly Publications for the PubMed Search Terms ‘‘Epigenetics,’’ ‘‘Long Term Potentiation,’’ ‘‘Synapse,’’ and ‘‘Neuron’’ for the
Years 1970–2013
Yearly data were generated using the Pubmed website, and their metrics were replotted for this figure. Please note that the numbers for the final year of these
graphs (2013) are projections based on the numbers of publications in each category as of September 25, 2013.
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fashion, promote gene transcription by loosening the chromatin
3-dimensional structure. This mechanism has specifically been
implicated in human cognitive function based on genetic studies
of intellectual disabilities (Ronan et al., 2013).
The RE1-silencing transcription factor (REST)/REST core-
pressor (CoREST)/Sin3A system is a well-established player in
neuronal/nonneuronal cell fate determination and indeed is likely
the best-understood epigenetic mechanism in play related to
neuronal function (Ballas and Mandel, 2005). This is a core
mechanism that silences nonneuronal genes in non-neurons
and, conversely, allows the broad segment of the genome that
is specifically necessary for neuronal function to be selectively
expressed in nerve cells.
A wide variety of noncoding RNAs have either been shown to
be or hypothesized to be involved in regulating cell function in the
nervous system, including piRNAs, microRNAs, small interfering
RNAs (siRNAs), and small nuclear RNAs (snRNAs) (Sun et al.,
2013; Tardito et al., 2013). These mechanisms have in common
the exquisite capacity for nucleotide sequence-specific effects,
allowing them to affect the function of particular genes with high
specificity. This is a burgeoning area for all of biology, including
(most recently) neurobiology.
Other relevant mechanisms include LINE 1 (long interspersed
nuclear element 1, aka L1) retrotransposition, in which the L1
class of repeat sequences can recombine and reinsert them-
selves into the genome using a copy-and-paste mechanism.
Through this mechanism, L1 elements can dramatically affect
gene transcription, and indeed the elements themselves are
capable of self-regeneration. Thus, they qualify as epigenetic
mechanisms based on these unifying criteria. However, L1
element recombination does not fit the classical definition626 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.of an epigenetic mechanism by virtue of the fact that they
modify gene transcription by changing the genomic nucleotide
sequence. Regardless of this, L1 retrotransposition in neurons
has largely been semantically regarded as an epigenetic mech-
anism in the CNS due to its striking functional similarity to other
epigenetic biochemical mechanisms. One compelling current
model for L1 function in neurons is that the mechanism drives
cellular heterogeneity at the genomic and functional level
through insertional mutagenesis (Muotri and Gage, 2006). The
broad context is that this allows individual neurons to achieve
genomic diversity and distinction from their siblings, broadening
the spectrum of cellular phenotypes driven by the single avail-
able genome in any particular neuronal subtype.
Finally, a provocative mechanism that has been proposed to
be important in sustaining long-term function changes in neu-
rons is a prion protein-basedmechanism. Prion proteins function
in yeast as nongenic heritable elements that potently regulate
cellular function and phenotype. These prion protein elements
are heritable, self-regenerating, and alter gene function, placing
them clearly in the epigenetic realm of biochemical processes.
Recent studies in theAplysiamodel system for studying synaptic
plasticity and memory have implicated a prion-protein-like
mechanism as being a long-term controller of synaptic efficacy,
specifically acting through the Aplysia cytoplasmic polyadenyla-
tion element-binding protein (ApCPEB; Bailey et al., 2004; Si
et al., 2004). This represents a particularly intriguing candidate
for a novel epigenetic mechanism operating to regulate neuronal
function.
The Emerging Subdiscipline of Neuroepigenetics
Over the last decade, there has been a great expansion of the
number of research papers and reviews published concerning
Table 2. Areas Where Epigenetic Mechanisms Have Been
Implicated in Human Nervous System Function
Function or Disorder Mechanism(s) Implicated
learning and memory histone modifications, DNA
methylation, piRNAs, miRNAs
maternal nurturing histone modifications, DNA
methylation
adult neurogenesis histone modifications, DNA
methylation
stress responses histone modifications, DNA
methylation
Alzheimer’s disease histone modifications, DNA
methylation
Rett syndrome MeCP2 methylcytosine binding
fragile X mental retardation DNA methylation, miRNAs
schizophrenia DNA and histone methylation,
miRNAs
Rubinstein-Taybi syndrome histone acetyltransferase
deficiency
Angelman syndrome genomic imprinting (DNA
methylation)
depression and/or suicide DNA methylation
bipolar disorder histone modifications, DNA
methylation, miRNAs
addiction and reward behavior histone modifications, DNA
methylation, miRNAs
PTSD histone modifications, DNA
methylation
ATR-X syndrome (a-thalassemia
mental retardation)
SNF2 chromatin remodeling, H3.3
cognitive aging histone modifications, DNA
methylation
Coffin-Lowry syndrome histone phosphorylation
Kleefstra syndrome histone methylation
epilepsy histone modifications, DNA
methylation, miRNAs
autism histone and DNA methylation?
miRNAs?
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related to adult CNS function. These burgeoning neuroscience
discoveries have necessitated a redefinition of epigenetics, at
least in regard to epigenetic mechanisms in adult neurons.
As mentioned already, epigenetic mechanisms were originally
defined as heritable either in a procreative organismal sense or
at the cellular level across cell division. However, the discovery
that those biochemical mechanisms listed in Table 1 are oper-
ating in adult neuronal function forces a reassessment; because
adult neurons are nondividing cells, obviously nothing happening
in them is heritable in the traditional sense. An epigenetic molec-
ular mark in an adult neuron can be long-lasting, permanent, and
self-regenerating but cannot be inherited by a daughter cell since
the neuron does not divide. This sets the roles of epigenetic
mechanisms in adult neurons apart from their roles in develop-
mental biology, such as perpetuation of cell fate determination,
heritability, genomic imprinting, etc. For this reason, along with
other unique attributes of the role of epigenetic molecular mech-
anisms in adult CNS function, Jeremy Day and I have proposed
adopting the term neuroepigenetic to help capture this distinc-
tion (Day and Sweatt, 2010). Regardless of that specific set of
semantic conventions, it also seems clear that the term neuroe-
pigenetic is emerging due to the discoveries of a wide variety of
roles for epigenetic molecular mechanisms in the CNS regarding
acquired behaviors, CNS disorders, neural plasticity, neurotox-
icity, and drug addiction (Table 2). Thus, we have the emerging
subdiscipline now being called neuroepigenetics.
A Daunting Dozen for the Emerging Subdiscipline of
Neuroepigenetics
For the remainder of this commentary, I will present my perspec-
tive concerning several open questions in neuroepigenetics at
present and for the next decade or so. I have tried to orient my
thoughts toward capturing some of the most challenging, but
vitally important, avenues of pursuit open to the field. I fully
realize that this is an incomplete list and that others working in
the area, such as Eric Nestler, Ted Abel, Li-Huei Tsai, Michael
Meaney, and Schahram Akbarian, would come up with different
lists (Sweatt et al., 2013). My hope in presenting the following
brief thoughts is that they might catalyze debate, discussion,
and further experimentation concerning the informational voids
that are outlined.
With this in mind, here are my own personal ‘‘daunting dozen’’
hot questions in neuroepigenetics.
1. Are Epigenomic Marks a Piece of the Engram?
Epigenetic molecular mechanisms certainly are a component of
developmental information storage, playing critical roles in cell
fate determination and lifelong perpetuation of cellular pheno-
type in both dividing and nondividing cells. This is the scientific
context in which epigenetic mechanisms were originally pro-
posed to exist and in which they were discovered at the molec-
ular level. A broader question is whether epigenetic mechanisms
might be a more universal mechanism for cellular information
storage, operating to subserve plastic change in the adult CNS
and learned behavior at the organismal level.
The ability to form memories about both negative and positive
biological and emotional events is critical for human adaptive
behavior and decision making. Recent studies from a numberof laboratories has demonstrated a role for active DNA methyl-
ation and demethylation in regulating learning and memory for-
mation in the mammalian CNS (see Day and Sweatt, 2011 for a
review). Our understanding of this basic process is beginning
to have a far-reaching impact across disciplines, shedding new
light on scientific research into learning, memory, addiction,
stress disorders, and decision making. Thus, in recent years,
epigenetic modifications of DNA and chromatin have been iden-
tified as essential mediators of memory formation through the
regulation of gene expression (Sultan and Day, 2011), with
methylation of cytosines at CpG dinucleotides playing a critical
role in memory consolidation and stabilization over time (Feng
et al., 2010a; Lubin et al., 2008; Miller et al., 2010; Miller and
Sweatt, 2007; Monsey et al., 2011). However, a question in the
field that has been only sparsely investigated is whether epige-
netic mechanisms are necessary for ongoing storage of memory
(Miller et al., 2010; Lesburgue`res et al., 2011); in other words, areNeuron 80, October 30, 2013 ª2013 Elsevier Inc. 627
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Answering this question will have important implications
regarding both the long-standing question of the molecular
biology of the engram and whether there are universally shared
biochemical mechanisms for cellular information storage.
2. HowDoCell-wide Epigenomic Changes Interfacewith
Synapse-Specific Mechanisms of Neural Plasticity?
One of the most intriguing aspects of epigenetic mechanisms is
that they typically operate to drive cell-wide changes in gene
expression. Given the emerging role of epigenetic mechanisms
in learning and memory, this raises an apparent conundrum:
how do cell-wide changes in the neuron that are driven by
nuclear epigenomic marks fit into the well-established necessity
for synapse-specific plasticity as a mediator of memory? One
possibility is that they interdigitate with molecular species such
as synaptic tags in order to participate in synapse-specific
changes (Day and Sweatt, 2010). However, an intriguing alterna-
tive possibility is that epigenetic changes play to their strengths
and are purposely utilized for driving cell-wide functional
changes. Thus, a speculative notion is that the neuronal epige-
nome may be preferentially involved in non-Hebbian plasticity.
For example, epigenetic molecular mechanisms may be particu-
larly relevant to various forms of metaplasticity, operating to
establish a set point for biasing the entire cell toward or against
being susceptible to synapse-specific plasticity mechanisms
such as long-term potentiation. Similarly, the neuronal or glial
epigenome might be allocated to controlling intrinsic properties
that are themselves cell wide, such as excitability and activity-
dependent synaptic scaling. Conceptually, the epigenome, hav-
ing the capacity to control the entire genomic output and sense
pancellular signalingmechanism,might be the ideal control point
for achieving coordinated orchestration of the readout of a
plethora of ion channels, receptors, and trafficking mechanisms
in order to achieve homeostatic plasticity.
3. How Is DNA Methylation Actively Regulated in
Neurons?
While early studies identified 5-methylcytosine as a stable tran-
scriptional silencer based on its role in tissue-specific gene
expression, X chromosome inactivation, and gene imprinting
(Bonasio et al., 2010; Feng et al., 2010b), new evidence of rapid
and reversible changes in DNA methylation at memory-associ-
ated genes implies the presence of both active DNAmethylation
and active DNA demethylation processes in response to
neuronal activity (see Miller and Sweatt, 2007; Lubin et al.,
2008 for examples). The upstream signaling mechanisms that
control both activity-dependent inducible increases in methyl-
ation and active cytosine demethylation in the nervous system
are completely mysterious at present. Those signaling mecha-
nisms regulating histone modifications are better understood,
but our understanding of even those pathways may be best
described as a working sketch (Bonasio et al., 2010). Thus, an
important area for further research is investigating how things
like action potential firing, membrane depolarization, and neuro-
transmitter and hormone receptor activation signal the epige-
nome to change. By extension, an open question in all of
epigenetics is how histone modifications interact with the cyto-
sine methylation apparatus in order to trigger and perpetuate
changes in epigenomic structure.628 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.The recent discovery of novel oxidative modifications of meth-
ylcytosine in the nervous system is quite exciting, and these find-
ings further enrich the picture concerning how DNA methylation
is regulated in the nervous system. Hydroxymethylcytosine is
emerging as the active demethylation mark that targets a spe-
cific 50-methyl group on cytosine for net removal by a complex
base excision repair mechanism (Guo et al., 2011a; 2011b).
Moreover, as was already mentioned, hmC is of highest abun-
dance in the fertilized zygote and the adult CNS, tissues that
might be thought of as hyperplastic relative to other cell types
in mammals, further implicating this chemical species as a
potential plasticity mechanism for the epigenome.
Consistent with the idea that hmC is involved as a specific
mechanism for active cytosine demethylation, recent studies
identified the ten-eleven translocation (Tet) family of proteins in
active DNA demethylation (Ito et al., 2010; Kriaucionis and
Heintz, 2009; Tahiliani et al., 2009). Specifically, Tet1, Tet2,
and Tet3 enzymes regulate the oxidation of 5mC to 5-hydroxy-
methyl cytosine (5hmC) (Ito et al., 2010; Kriaucionis and Heintz,
2009; Tahiliani et al., 2009), which is deaminated to 5-hydroxyur-
acil (5hmU) (Guo et al., 2011b; Popp et al., 2010; Zhu, 2009) to
create a 5hmU:G mismatch that is recognized and removed by
one of several glycosylases. This abasic site is then repaired
by the base excision repair (BER) machinery, resulting in overall
demethylation of a specific cytsosine. Further Tet-mediated
oxidation of 5hmC to 5-formylcytosine (5fC) and 5-carboxylcyto-
sine (5caC) can also occur prior to glycosylase excision and BER
(Ito et al., 2011).
Recent studies specifically investigating the role of TET1 oxi-
dase in the nervous system provided direct evidence for this
model of TET oxidase control of active DNA demethylation in
the CNS and indeed of a role for this pathway in memory forma-
tion and storage (Kaas et al., 2013; Rudenko et al., 2013). Overall,
these results mark a substantial advance and reveal new infor-
mation about how plasticity of neuroepigenetic marks regulates
activity-dependent processes within the central nervous system.
4. How Is One Specific Cytosine from a 3 Billion-
Nucleotide Cellular Genome Specified for Chemical
Modification?
This is one of the biggest open questions in all of epigenetics, not
just neuroepigenetics, and applies equally to both methylation
and demethylation. It is clear on its face that mechanisms for
identifying genomic sites for selective epigenetic modification
must exist; the epigenome has specificity and structure, with
specific individual genes, exons, promoter regions, gene bodies,
alleles, and even specific cytosines being methylated or deme-
thylated. Moreover, these modifications can occur at both CpG
sites and non-CpG sites, so even the previously held minimal
methylation consensus sequence of a C-G dinucleotide no
longer holds. But there is no current mechanistic explanation
for how this specificity of cytosine methylation can happen.
I, and many others in the field, speculate, based on first princi-
ples, that the mechanisms must be directed to specific loci in
some fashion based on nucleotide sequence—it seems to be
the only component of the system with adequate informational
content. In this regard, noncoding RNAs serving as a targeting
template is one appealing mechanism. Indeed, the recent land-
mark finding from the Kandel lab regarding piRNAs directing
Neuron
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sory neurons may be a key insight (Rajasethupathy et al., 2012;
Landry et al., 2013). However, it is unclear if those mechanisms
operate in the mammalian CNS at present, and this is a hypoth-
esis that warrants vigorous investigation.
5. What Roles Do Epigenetic Mechanisms Play in
Complex Human Diseases of the Nervous System?
As illustrated in the list in Table 2, this is an extremely broad
question, and obviously I cannot discuss it in detail in a brief
commentary such as this. However, I will note that epigenetic
mechanisms may be particularly relevant to multifactorial dis-
eases with low genetic penetrance, such as schizophrenia and
depression (Petronis, 2010). Thus, epigenomically based mech-
anisms for these disorders may help fill a void where, historically,
genomic analyses have not led to clearly identifiable causes. In
addition, disorders that are triggered by just one or only a few
experiences, but that are henceforth enduring, also seem likely
candidates to be epigenetically mediated. In this line of thinking,
disorders such as drug addiction, posttraumatic stress disorder
(PTSD), epilepsy, and schizophreniamight selectively involve the
cooptation of epigenetic mechanisms used for development and
learned behavior to subserve behaviorally disadvantageous, but
obdurate, behavioral change.
6. Will Epigenetically Targeted Drugs Allow the
Development of Novel Neurotherapeutics?
This is the corollary to the preceding question—if epigenetic
mechanisms are broadly involved in CNS disorders, might
epigenetic targets as a category be broadly applicable to drug
development? This is a very active area of investigation at pre-
sent, with drug discovery efforts ongoing in the areas of cognitive
enhancers for learning disabilities, Alzheimer’s disease, neuro-
degenerative disorders, schizophrenia, depression, addiction,
generalized stress disorders, and PTSD (Kazantsev and Thomp-
son, 2008; Fischer et al., 2007; Anier et al., 2010; Kilgore et al.,
2010; Peleg et al., 2010; Renthal and Nestler, 2008; Szyf, 2009,
Monsey et al., 2011; Oliveira et al., 2012).
7. Are Acquired Epigenetic Marks Transmitted Across
Generations?
Some aspects of this question are among the most contentious
areas in the epigenetics field at present. Broadly speaking,
epigenetic transgenerational effects come in two flavors. The
first type is not transgenerational in the heritable sense, but
rather is experience dependent. For example, Michael Meaney’s
group, his collaborators, and scientific descendants have
demonstrated that maternal nurturing behavior regarding
newborn pups triggers DNA methylation changes in CNS gluco-
corticoid receptors of offspring that persist into the adult and
effect behavioral change (Champagne and Curley, 2009;Weaver
et al., 2004, 2005). Discovery of these experience-dependent
changes in the epigenome is the prototype for the first category
of transgenerational effects, and such experience-driven epige-
nomic changes in the CNS have been documented to occur with
a number of both positive and negative environmental effects in
offspring. Thus, several examples of the persisting CNS epige-
nomic effects on offspring of parental behavior and environ-
mental insult have survived the rigors and skepticism of peer
review (Champagne and Curley, 2009; Roth et al., 2009). At the
most basic level, these studies demonstrate that early life expe-riences can trigger lifelong persisting epigenomic changes in the
brain of an individual, an observation that has clear implications
for how epigenetic mechanisms might contribute to CNS health
and pathogenesis over the lifespan.
The second flavor of transgenerational effect is the idea that
experience-driven epigenetic changes in an animal might lead
to heritable DNA methylation changes that are propagated
through the germline through many or all subsequent genera-
tions. This neo-Lamarckian scenario is a truly frightening possi-
bility, with interesting implications for topics such as free will, and
is being hotly debated even as a possibility at present. A pre-
sumed evolutionary role for these types of mechanisms is ‘‘soft
inheritance,’’ wherein environmental experience/exposure could
trigger heritable epigenomic changes that improve survival
over a few generations but are ultimately reversible because
they are based upon epigenomic changes (epimutations) and
not upon directly altering the offspring’s DNA nucleotide
sequence. There are several tantalizing and fascinating indica-
tions of experience-dependent heritable changes in the CNS
epigenome in the literature at this point, involving maternal
behavior, paternal behavior, diet, exposure to drugs of abuse,
and endocrine disruption (Bohacek et al., 2013). Definitively
determining whether experience-driven, acquired epigenetic
changes can propagate through the germline and effect behav-
ioral change in subsequent generations is one of themost impor-
tant areas of contemporary neuroepigenetics research, in my
opinion. Proof of the existence of such mechanisms has the
potential to fundamentally change our outlook on evolutionary
biology, psychobiology, and neurophilosophy.
8. What Is the Role of DNA Recombination in CNS
Development and Function?
In the background section above, I included a brief description of
LINE 1 retrotransposition in neurons, in which the L1 class of
repeat sequences recombine and reinsert themselves into the
genome. As I already alluded to, strictly speaking this is not an
epigenetic mechanism because it involves a change in nucleo-
tide sequence. However, this area has been adopted by neuro-
epigeneticists because the mechanistic and functional roles
are so similar to epigenetic mechanisms, and this mechanism
fits quite well into the current novelty and mysteriousness of
epigenetic mechanisms in the nervous system.
The existence of this mechanism in neurons in the CNS implies
the existence of a biochemical system that is capable of produc-
ing genomic diversity at the level of individual neurons, which in
principle would be a potent force for generating idiosyncratic ge-
notypes (presumably useful) for specific neurons or subgroups of
neurons. The laboratory of Rusty Gage has led the way in estab-
lishing the existence of this mechanism in the CNS (Muotri and
Gage, 2006). Testing the functional roles of this type of genomic
diversity, both in the workings of the individual cell and in the
context of organismal behavior, may result in paradigm-shifting
models for control of neuronal function. Regardless of the pre-
cise functional model for the effects of these transposable
genetic elements in neurons, the existence of the requisite
molecular machinery in the CNS is clear. Documentation of the
phenomenon of genomic plasticity in the brain is iconoclastic
in its own right, potentially akin to the discovery of DNA recom-
bination as a driver for antibody diversity in the immune system.Neuron 80, October 30, 2013 ª2013 Elsevier Inc. 629
Neuron
Perspective9. What New Roles for Epigenetic Mechanisms in Neural
Development Await Discovery?
Epigenetic mechanisms were, of course, first hypothesized to
exist and then discovered to exist in the field of developmental
biology (Ng and Gurdon, 2008; Tate et al., 1996; Feng et al.,
2010b). Thus, our understanding of the developmental roles of
epigenetic mechanisms is the most mature area of this relatively
young field. Epigenetic mechanisms are a core process driving
cell fate determination and especially cell fate perpetuation.
However, by no means does this imply that novel developmental
epigenetic regulators are not out there to be found, nor that
distinct developmental uses of known mechanism cannot exist.
This represents a rich field for additional research, especially, in
my opinion, as relates to noncoding RNAs and their role in CNS
development.
Moreover, the existing developmental models of epigenomic
effects are largely based in the broad concept that epigenetic
marks are essentially immutable once laid down, in order to
perpetuate cellular phenotype over time. The new understanding
of dynamic regulation of DNA methylation in the nervous system
forces a rethinking of the basic tenet of epigenetics. What new
mechanisms are there to be found in terms of active regulation
of the epigenome during neuronal, glial, and nervous system
development, especially regarding the effects of neural activity
and behavioral experience as it shapes the developing nervous
system? Furthermore, the plastic nature of the neural epigenome
has immense implications for neurodevelopmental disorders
that were previously assumed to be irreversible, given that cells
in the CNSmight be subject to epigenetic reprogramming later in
life (Ehninger et al., 2008, Weeber and Sweatt, 2002, Jiang et al.,
1998).
Finally, a particularly intriguing area regarding this overall
question is the phenomenon of genetic imprinting, wherein the
paternal ormaternal allele of a gene can be epigenetically tagged
to modify its function. Allelic imprinting can go so far as to
completely silence one allele of a given gene in a cell type or brain
region. It has been proposed that imprinting mechanisms may
bias one allele to be preferentially used at one developmental
stage, essentially preserving an epigenetically fresh copy of the
same gene for distinct epigenetic regulation somewhere down
the timeline (Day and Sweatt, 2011; Gregg et al., 2010a;
2010b). Testing this idea awaits further investigation.
10. How Can a Single Cell Have Both a Stable
Developmental Epigenome and a Dynamically
Regulated One as Well?
The discussion in point 9 leads us to the next question, because
on its face it seems that there must be unique mechanistic chal-
lenges to utilizing the biochemical machinery that allows
dynamic activity-dependent modification of the epigenome in a
terminally differentiated and nondividing cell such as a neuron
(Feng et al., 2010b). Thus, active regulation of epigenetic marks
in a neuron must exist simultaneously alongside the stable
epigenetic marks that perpetuate neuronal phenotype over
the lifespan. How can a single genome be subject to both
perpetual and immutable epigenetic marking at the same time
it is subject to dynamic regulation in response to experience?
This thought experiment tells us that some set of mechanisms
must compartmentalize the developmental epigenome from630 Neuron 80, October 30, 2013 ª2013 Elsevier Inc.the dynamic epigenome. These mechanisms are completely
mysterious at present.
11. What Is the Extent of Involvement of Protein-Based
Epigenetic Mechanisms in Nervous System Regulation?
As described in the introductory section, epigenetic mecha-
nisms are so powerful because they can self-perpetuate over
time. Indeed, this peculiar aspect of epigenetics is why Francis
Crick first proposed DNA methylation as a component of mem-
ory storage in the nervous system in a personal correspondence
to the editor at Nature (Crick, 1984). However, as described
above, self-perpetuating epigenetic mechanisms are not limited
to DNA modifications—prion-like mechanisms, histone subunit
exchange, and histone methylation all have the demonstrated,
or at least hypothetical, capacity for self-regeneration in the
face of protein turnover. Presumably, other self-reinforcing
protein-based mechanisms await discovery, and their potential
roles in neuronal information storage are tantalizing.
12. Can we Really Understand the CNS Epigenome?
My final question for this perspective piece is whether, as scien-
tists, we will ever be able to fully comprehend the mechanistic
roles of neuroepigenetic mechanisms in any sort of compelling,
understandable, and satisfying fashion. It might be a reality
that the neuroepigenetic mechanisms operating in the CNS are
so complex that they defy comprehensive explanation and
understanding. I certainly hope this is not the case! But as a
closing comment, I would like to explain my fear in this regard.
Explaining how neuroepigenetic mechanisms serve as the
interface between genes and experience, or nature and nurture
as I mentioned to start this essay, is certainly going to be a big
data endeavor. It is already clear that tracking epigenetic
changes in the CNS over the lifespan is going to be a huge bio-
informatics challenge (Lister et al., 2013). The biomedical poster
child for big data thus far has been sequencing the human
genome, aswell as the genomes of other species. This is the pro-
totype for how we think about large-scale bioinformatics initia-
tives in biology: sequencing and annotating the 3 billion or so
nucleotides comprising a mammalian genome. However, the
genome in all its complexity is simply the basic first layer of infra-
structure upon which epigenetic mechanisms operate. A single
mammalian organism has a single genome, but that same organ-
ism has hundreds of cellular phenotypes, each of which has its
own distinct epigenome. Each cellular epigenome itself com-
prises a hundred or so distinct epigenetic marks (Table 1) that
can potentially be read out in a complex combinatorial fashion,
that can potentially have functional consequences specifically
localized to any one of the 3 billion or so individual nucleotides
in the cell. So, conceptually, one can multiply 3 billion nucleo-
tides (the genome) times 100 potential epigenetic marks that
may or may not be there at each nucleotide, each epigenetic
mark of which exists in some background epigenome specifying
cell type and which may be read out in a combinatorial fashion
depending upon nearby epigenetic modifications (Scharf and
Imhof, 2011; D’Alessio and Szyf, 2006). The potential combina-
torial complexity of this system is indeed daunting. Deciphering
how the epigenome regulates the functional properties of neu-
rons and glia in the brain is clearly going to be an immense bio-
informatics challenge. The workings of the epigenomic code in
the CNS will certainly be refractory to succinct and simple
Neuron
Perspectiveexplanation. However, it is already clear that parsing that code
will be required for any comprehensive model of how experience
shapes function in the brain.
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